Gala GLP-1 Review: Questions to Settle Before Paying, Prescribing and Renewal

Before completing Gala GLP-1’s intake form, ask one unusually important question: what happens financially when I submit it? The subscription policy says membership begins, and the first month is charged, when intake is completed. That makes the questionnaire more than a preliminary expression of interest. For someone comparing programs, the practical starting point is to understand the payment trigger before entering the clinical review process—not after a prescription decision or package shipment.

Gala documents a real GLP-1 access model: a platform connecting adults with independent medical practices and third-party pharmacies. It advertises compounded semaglutide or tirzepatide injections, branded Ozempic, nationwide access and continuing support. But the advertised monthly amounts, annual or three-month plan conditions, cancellation deadline and conflicting refund language deserve separate attention. This review examines public documentation consulted October 19, 2026, translating those distinctions into questions a prospective patient can take to Gala without treating advertising as verified clinical performance.

At a glance

Who delivers care: AI Coaching Inc., doing business as Gala GLP-1, operates the platform. Independent medical practices provide care, and third-party pharmacies dispense prescriptions.
Sources: [9] [11]
Compounded-plan prices: The compounded GLP-1 page advertises pricing from $179/month with a yearly subscription. The homepage advertises starting at $199/month with a three-month plan; final pricing depends on medication and plan.
Sources: [13] [11]
Ozempic price: Ozempic starts at $1,299/month cash price, with a provider visit and free shipping advertised. Insurance may reduce the cost; FSA and HSA payments are accepted.
Sources: [15]
First charge: The subscription policy says the first month is charged when the intake form is completed, rather than establishing shipment as the billing trigger.
Sources: [14]
Cancellation deadline: Cancellation requests must be received at least 72 hours before billing. Missing that deadline means another charge, with cancellation taking effect on the subsequent billing date.
Sources: [14]

What exactly am I agreeing to pay?

Gala’s lowest prominently documented compounded price is not an unconditional month-to-month offer. Its compounded GLP-1 page says “From $179/month” and “Yearly subscription,” with all doses, a provider visit and free shipping included; it also lists FSA and HSA acceptance. Separately, the homepage advertises access starting at $199 per month with a three-month plan. Neither statement alone establishes the initial total collected, medication quantity shipped or financial consequences of leaving an annual arrangement early.

There is another price presentation worth resolving before checkout. Gala’s tirzepatide information page describes compounded GLP-1/GIP treatment, including tirzepatide, as $199 per month with medical evaluation and ongoing support, then displays “Start for $179/mo” without explaining the commitment there. These are not interchangeable offers. Ask for a written, product-specific quote identifying the plan duration, first charge, subsequent charges and whether the displayed monthly amount is collected monthly or through another arrangement.

The policy says the first month is charged upon completion of intake. Its single subscription price may cover consultations, laboratory services, medication and support, but covered services, labs and medicines can vary. Ask which tests are required and whether they are included in your particular quote. Our questions beyond the monthly price offer a useful framework: separate the billing schedule, included care and medication supply rather than assuming one advertised period answers all three.

Gala’s documented price presentations—and what to clarify
Offer	Published terms	Question before payment
Compounded GLP-1	From $179/month; yearly subscription; all doses, provider visit and free shipping advertised	What is collected initially, and what happens if I leave the yearly plan?
Homepage compounded offer	Starting at $199/month with a three-month plan; final price depends on plan and medication	What is my exact medication-specific checkout total and billing schedule?
Tirzepatide information page	$199/month with evaluation and support; adjacent $179/month starting offer	Which commitment and product apply to each displayed amount?
Ozempic	From $1,299/month cash price; visit and free shipping included; insurance may reduce cost	What will I owe after any confirmed coverage?
Subscription inclusions	Consultations, labs, medication and support may be covered; coverage varies	Which services or tests, if any, are charged separately?

Sources: [13] [11] [8] [14]

Who is responsible when I need an answer?

Gala GLP-1 is the operating name of AI Coaching Inc. Its terms say it facilitates telehealth consultations but neither practices medicine nor operates as a pharmacy. The site assigns medical services to licensed physicians and clinicians at independently owned practices, including OpenLoop-affiliated groups and other affiliated practices. This division matters: the company collecting a subscription payment is not necessarily the medical practice making a prescribing decision or the pharmacy resolving a dispensing problem.

Ask for the name of your treating practice, the clinician’s professional credentials and the dispensing pharmacy before relying on broad descriptions of a coordinated team. The consulted documentation does not identify the dispensing pharmacies by name or independently verify individual licenses. Gala also states that it does not handle or ship medication and disclaims responsibility for dispensing errors. A useful enrollment answer should explain how its support team connects you to the party actually responsible for resolving a problem.

The terms publish team@galaglp1.com and an address at 1007 N Orange St., 4th Floor, Suite #2920, Wilmington, Delaware 19801. The privacy policy says health information is shared with licensed providers and partner pharmacies to facilitate appropriate care and prescriptions. Ask which contacts handle billing, clinical questions and pharmacy issues, and where each conversation is recorded. Gala separately states that it is independent and not affiliated with Novo Nordisk or Eli Lilly.

Sources: [9] [11] [10] [7]

Which medicine is actually being offered to me?

Gala’s weight-loss catalog lists compounded semaglutide or tirzepatide as weekly injections and displays them as in stock. Its marketing specifically addresses women, but that positioning should not be expanded into an undocumented eligibility rule. Ask for the exact prescribed preparation, route, presentation and pharmacy rather than treating “GLP-1” as a complete product description. Gala says compounded medicines come from licensed compounding pharmacies and acknowledges that they are not FDA approved; those are provider statements, not independent pharmacy verification.

FDA explains that compounded preparations do not undergo its premarket review for safety, effectiveness and quality. It recommends compounded drugs when an individual’s medical needs cannot be met by an FDA-approved drug, with a prescription and a state-licensed pharmacy. Nonapproval alone does not prove clinical inequivalence or establish whether a particular provider’s service is appropriate. The useful question is why the proposed preparation addresses your medical needs—not whether a platform’s branding makes the preparation FDA approved.

Gala also advertises branded Ozempic, identified as Novo Nordisk’s semaglutide product. Its oral Wegovy page, however, is a waitlist conditioned on FDA approval and supply, not confirmation of an available prescription option. That page’s language should not be treated as an independent statement of current regulatory status. Ask what can actually be prescribed and filled now. Our medication-identification questions can help keep a current offer separate from a catalog entry or future-product promotion.

Sources: [5] [11] [15] [6] [1]

What happens between intake and a prescription decision?

Gala describes an assessment covering the applicant’s body, medical history and goals, followed by review of the complete profile by a U.S.-licensed clinician. The clinician may prescribe or return with questions. Its terms explicitly say a prescription is not guaranteed and remains solely within the licensed provider’s discretion. Because payment begins at intake completion, ask how you will learn the decision, what happens if more information is needed and which refund provision applies if treatment is medically ruled out.

The service requires users to be at least 18 or the age of majority in their jurisdiction. Gala’s semaglutide page describes possible candidacy at a BMI of 27 or higher with weight-related conditions, or 30 or higher without requiring comorbidities. Its tirzepatide page names certain medical histories as reasons treatment may not be recommended and assigns eligibility review to clinicians. These are screening descriptions, not an individualized determination; a questionnaire threshold cannot guarantee access to a particular prescription.

Consultations may use video or asynchronous messaging depending on the patient, state law or medication. Gala says a required video visit is typically the initial session, while follow-up questions and adjustments may occur through chat. Ask whether your own assessment requires an appointment, additional records or laboratory testing. NIDDK recommends discussing current medicines, supplements, allergies and pregnancy plans with the clinician; preparing that information is more useful than expecting a documentary review to decide eligibility.

Sources: [9] [5] [12] [8] [11] [2]

Will my state, insurance and delivery address change the offer?

Gala advertises access to GLP-1 medications in all 50 states. That is a provider availability claim, not confirmation that every listed medication is available to every applicant in every state. Ask whether the particular prescription, pharmacy and consultation format are available for your location. The consulted documentation also does not confirm Spanish-language care or interpreter access. Anyone needing language assistance should establish how clinical instructions and follow-up communication will be provided before paying.

Insurance is not required to use Gala. For Ozempic, the advertised starting cash price is $1,299 per month, including a provider visit and free shipping, with FSA and HSA acceptance listed. Gala says insurance may reduce that amount and that coverage is checked during assessment; it also says coverage for weight loss alone is harder. Do not treat a coverage check as an approval. Ask for the cash obligation if coverage is denied and verify benefits directly with the health plan.

For delivery, Gala advertises discreet packaging, refrigeration when needed and free shipping. Its weight-loss page promotes seven days from assessment to medication at the door, but does not establish separate clinical-review, pharmacy-preparation or transit deadlines. Ask when the estimate starts, what could delay it and who communicates a revised timeline. An advertised end-to-end interval does not tell you when the prescription will be approved, the package dispatched or a specific delivery date guaranteed.

Sources: [11] [15] [5] [2]

What support is available after the package arrives?

Gala advertises 24/7 patient support and provider support for as long as treatment continues. Those statements do not establish immediate access to a prescribing clinician or a scheduled clinical follow-up interval. Ask who answers an overnight message, how a medical concern is escalated and the expected clinician response time. Its terms exclude urgent and emergency medical situations. The distinction between customer support and clinical care is especially important when the same interface also handles orders and payments.

The app is described as a place for medical visits, prescription renewals, team communication, appointment updates, past orders and package tracking. Gala also says a clinician may modify treatment and that a recommended higher dose carries no additional cost. Confirm how that promise applies to your selected product and plan, and what reviews precede a refill. Our questions about ongoing support focus on responsibilities and access rather than assuming an app notification equals a clinical assessment.

For delivery problems, Gala’s policy says damaged items may be replaced by the pharmacy after evidence of damage, while incorrect medications will be replaced. FDA separately advises not using an injectable GLP-1 drug that arrives warm or insufficiently refrigerated and contacting the provider or dispensing pharmacy. Ask in advance where to send photographs, temperature concerns or an incorrect-item report. FDA also reports compounded-medication measurement errors, making clear prescriber or pharmacist instructions essential; this review cannot provide dosing calculations.

Sources: [11] [5] [7] [14] [9] [1]

How do I stop renewal without confusing cancellation and refund?

Gala’s advertising says “Cancel anytime,” but its policy sets an operational deadline: the request must be received at least 72 hours before the billing date. Otherwise, another cycle is charged and cancellation takes effect on the subsequent billing date. Requests go through customer service or an online-account process if available. Ask for the exact billing date, applicable time zone and written confirmation of receipt. Do not assume submitting a request near renewal prevents the next charge.

After cancellation, the policy says access continues through the end of the billing cycle. It does not generally promise money back: outside medical disqualification, it expressly excludes refunds upon cancellation. A separate provision limits approved refunds to the most recent billing cycle, excluding earlier cycles. These distinctions matter particularly for the yearly advertised offer, because the public material does not settle its initial collection structure or early-exit consequences. Cancellation permission alone does not answer either question.

Medical-disqualification language also needs clarification. One passage promises a full refund if the provider disqualifies a patient for a medical reason; another describes a refund of remaining subscription charges following disqualification. Ask which amount is refundable before the first prescription versus after treatment has begun, and request the answer in writing. Our questions to settle before renewal can help organize those details. The consulted documentation does not resolve the competing descriptions into one unambiguous refund calculation.

Sources: [13] [14]

What should a complete answer from Gala look like?

A useful pre-enrollment response would connect the offer’s separate parts: the named medicine and pharmacy, treating practice, consultation format, required tests, exact initial payment, next billing date and cancellation procedure. Gala documents pieces of that pathway, but not a complete patient-specific version. Ask for one written summary rather than collecting reassuring fragments from different product pages. In particular, “all doses included” does not identify supply quantity, and a yearly subscription label does not explain how often medication ships.

The next question concerns care rather than checkout: when will the clinician review tolerance and response, and how can you reach that clinician between reviews? Gala describes chat follow-up and included provider support but does not publish a fixed review cadence or clinician response deadline in the consulted material. NIDDK describes medication selection as involving health conditions, other medicines, side effects, benefits and cost. That is a broader discussion than whether a subscription successfully renews.

Finally, distinguish access documentation from outcome evidence. A product listing, a licensed-provider claim and a pharmacy arrangement do not establish how much weight a Gala patient will lose. The clinical trials in the broader evidence base are not trials of Gala’s compounded products or its service. For this decision, the strongest use of the public record is to identify what Gala promises, what a clinician must determine and what still needs a specific answer before money changes hands.

Sources: [11] [5] [13] [14] [2] [3] [4]

Questions & answers

Can I get Gala’s $179 price without an annual subscription?

The compounded GLP-1 page explicitly ties its starting $179 monthly amount to a yearly subscription. Another page displays a $179 starting callout without explaining that commitment locally. The documentation does not establish an unconditional $179 month-to-month option. Ask Gala for the exact plan terms, initial collection and renewal schedule before completing intake.

Sources: [13] [8]

Does Gala charge before I know whether I will receive a prescription?

Its policy says the first month is charged when the intake form is completed, while its terms reserve prescribing decisions to the clinician and guarantee no prescription. Medical-disqualification refund provisions exist, but their descriptions differ. Ask how the charge and refund process works if the clinician declines treatment or requests information that delays a decision.

Sources: [14] [9]

Is Gala itself my medical provider or pharmacy?

No. Gala identifies itself as the platform and says independent medical practices provide care, including OpenLoop-affiliated groups and other affiliated practices. Third-party pharmacies dispense prescriptions. Ask for your own practice and pharmacy names, plus separate contact instructions for clinical questions, dispensing problems and subscription billing. The consulted documentation does not name the dispensing pharmacies.

Sources: [9] [11]

Can Gala help me use insurance for Ozempic?

Gala says it checks coverage during assessment and that insurance may reduce its starting $1,299 monthly cash price. It also notes that weight-loss-only coverage is harder. That is not a guarantee of payment by your insurer. Confirm the benefit, any patient responsibility and what Gala will charge if coverage is not approved before relying on an estimated insured price.

Sources: [15]

Is oral Wegovy currently available through Gala?

The consulted Gala page does not confirm current availability. It offers a waitlist and conditions access on FDA approval and supply, without establishing a launch date or price. Treat that as the status of Gala’s documented offer, not an independent regulatory update. Ask which currently available product, if any, would actually be prescribed and dispensed to you.

Sources: [6]

Will canceling today prevent Gala’s next charge?

Only if the request meets the policy’s timing requirements: it must be received at least 72 hours before billing. A later request results in another charge, with cancellation effective on the subsequent billing date. Keep written confirmation. Ending renewal does not itself create a refund entitlement, and the annual offer’s early-exit financial treatment still needs clarification.

Sources: [14] [13]

Our assessment

Gala’s documented strengths are a clearly described telehealth access model, multiple advertised medication options, digital order and visit tools, and published cancellation rules. Its headline offers also identify several inclusions rather than leaving every component unpriced. The unresolved points are consequential, however: the annual plan’s initial collection and exit terms, medication-specific final prices, named pharmacies, laboratory requirements, clinician response times and inconsistent medical-disqualification refund wording. A sensible next step is to request a written, patient-specific offer before completing the intake that triggers billing. If Gala clearly identifies the care team, medication, complete payment schedule and applicable refund calculation, comparison becomes more meaningful. If those answers remain general, the public documentation alone is not enough to establish the financial commitment or day-to-day care experience.

Visit Gala GLP-1’s official site ↗

This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.

Sources & documentation

Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.

Gala GLP-1 Review: Questions to Settle Before Paying, Prescribing and Renewal

At a glance

01What exactly am I agreeing to pay?

02Who is responsible when I need an answer?

03Which medicine is actually being offered to me?

04What happens between intake and a prescription decision?

05Will my state, insurance and delivery address change the offer?

06What support is available after the package arrives?

07How do I stop renewal without confusing cancellation and refund?

08What should a complete answer from Gala look like?